Product Information
MODAFINIL 200 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.3436 per EA under NDC 69452034319. Its NADAC has been published 105 times since Oct 2, 2024.
FDA first approved this application on Sep 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Bionpharma Inc.NDC
69452034319
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MODAFINILApproval Type
Generic (ANDA)
FDA Application
ANDA078963FDA Approved
9/26/2012
TE Code
AB
On Market Since
2/28/2022
Pharmacological Classes
Price Statistics
The NADAC for MODAFINIL 200 MG TABLET has been published 105 times since Oct 2, 2024, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3436 per EA |
|---|---|
| All-time high | $0.4092 (Jan 14, 2026) |
| All-time low | $0.2911 (Nov 20, 2024) |
| 52-week high | $0.4092 |
| 52-week low | $0.3436 |
| Median price | $0.3677 |
| Average price | $0.3631 |
| Largest weekly change | -18.3% (Nov 20, 2024) |
| Weeks tracked | 105 |
| Tracking since | Oct 2, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Modafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sympathomimetic-like Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MODAFINIL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MODAFINIL 200 MG TABLET, manufactured by Bionpharma Inc., is $0.3436 per EA (NDC 69452034319), effective Sep 30, 2026.
How has the price of MODAFINIL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for MODAFINIL 200 MG TABLET has declined 12.1%. It has been tracked across 105 weekly CMS publications since Oct 2, 2024.
What are the highest and lowest recorded NADAC prices for MODAFINIL 200 MG TABLET?
Since Oct 2, 2024, the NADAC for MODAFINIL 200 MG TABLET has ranged from a low of $0.2911 (Nov 20, 2024) to a high of $0.4092 (Jan 14, 2026), with a median of $0.3677 per EA.
Are there cheaper alternatives to MODAFINIL 200 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MODAFINIL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MODAFINIL 200 MG TABLET?
MODAFINIL 200 MG TABLET (NDC 69452034319) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.